Wendy Tomlinson

1.2k total citations
14 papers, 757 citations indexed

About

Wendy Tomlinson is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Wendy Tomlinson has authored 14 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Physiology. Recurrent topics in Wendy Tomlinson's work include Adenosine and Purinergic Signaling (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Nitric Oxide and Endothelin Effects (2 papers). Wendy Tomlinson is often cited by papers focused on Adenosine and Purinergic Signaling (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Nitric Oxide and Endothelin Effects (2 papers). Wendy Tomlinson collaborates with scholars based in United Kingdom, United States and Brazil. Wendy Tomlinson's co-authors include Robert G. Humphries, Anthony H. Ingall, Peter J. Greasley, Fabrizio Giordanetto, J.J.J. van Giezen, P. Leff, J. A. Clegg, Nicholas D. Kindon, David Cox and Barry Teobald and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Wendy Tomlinson

14 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy Tomlinson United Kingdom 11 377 252 210 131 124 14 757
P. Schanzenbächer Germany 12 460 1.2× 53 0.2× 177 0.8× 144 1.1× 80 0.6× 30 782
David C. B. Mills United States 11 211 0.6× 127 0.5× 136 0.6× 276 2.1× 34 0.3× 15 676
Nathalie Delesque-Touchard France 7 166 0.4× 60 0.2× 197 0.9× 50 0.4× 32 0.3× 7 502
Nicholas A. Flores United Kingdom 14 319 0.8× 108 0.4× 140 0.7× 34 0.3× 11 0.1× 34 619
Toshiro Shibano Japan 17 541 1.4× 12 0.0× 188 0.9× 304 2.3× 274 2.2× 54 1.0k
JP Maffrand France 7 277 0.7× 24 0.1× 37 0.2× 73 0.6× 97 0.8× 9 396
Donald H. Namm United States 13 173 0.5× 45 0.2× 251 1.2× 39 0.3× 9 0.1× 16 579
Jeffrey S. Bostwick United States 15 161 0.4× 18 0.1× 65 0.3× 155 1.2× 95 0.8× 23 397
Shin-ichiro Ashida Japan 14 202 0.5× 8 0.0× 121 0.6× 124 0.9× 40 0.3× 27 606
PJ Kadowitz United States 6 209 0.6× 19 0.1× 114 0.5× 47 0.4× 12 0.1× 7 650

Countries citing papers authored by Wendy Tomlinson

Since Specialization
Citations

This map shows the geographic impact of Wendy Tomlinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Tomlinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Tomlinson more than expected).

Fields of papers citing papers by Wendy Tomlinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Tomlinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Tomlinson. The network helps show where Wendy Tomlinson may publish in the future.

Co-authorship network of co-authors of Wendy Tomlinson

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Tomlinson. A scholar is included among the top collaborators of Wendy Tomlinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Tomlinson. Wendy Tomlinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Mackay, Laura, Iain G. Dougall, Wendy Tomlinson, et al.. (2013). Isolation and characterisation of human pulmonary microvascular endothelial cells from patients with severe emphysema. Respiratory Research. 14(1). 23–23. 13 indexed citations
2.
Scott, Ian, Wendy Tomlinson, Andrew Walding, Beverley Isherwood, & Iain G. Dougall. (2013). Large‐scale isolation of human skeletal muscle satellite cells from post‐mortem tissue and development of quantitative assays to evaluate modulators of myogenesis. Journal of Cachexia Sarcopenia and Muscle. 4(2). 157–169. 21 indexed citations
3.
Luckhurst, Christopher A., M. Ratcliffe, Mark Furber, et al.. (2010). Synthesis and biological evaluation of N-alkylated 8-oxybenz[c]azepine derivatives as selective PPARδ agonists. Bioorganic & Medicinal Chemistry Letters. 21(1). 531–536. 10 indexed citations
4.
Luckhurst, Christopher A., Mark Furber, M. Ratcliffe, et al.. (2010). Discovery of isoindoline and tetrahydroisoquinoline derivatives as potent, selective PPARδ agonists. Bioorganic & Medicinal Chemistry Letters. 21(1). 492–496. 25 indexed citations
6.
Doyle, Ian, M. Ratcliffe, Andrew Walding, et al.. (2009). Differential gene expression analysis in human monocyte-derived macrophages: Impact of cigarette smoke on host defence. Molecular Immunology. 47(5). 1058–1065. 28 indexed citations
7.
Giezen, J.J.J. van, et al.. (2009). Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP‐induced receptor signaling and platelet aggregation. Journal of Thrombosis and Haemostasis. 7(9). 1556–1565. 214 indexed citations
8.
Jin, Jianguo, et al.. (2001). The C6‐2B glioma cell P2YAC receptor is pharmacologically and molecularly identical to the platelet P2Y12 receptor. British Journal of Pharmacology. 133(4). 521–528. 46 indexed citations
9.
Jarvis, Gavin E., Robert G. Humphries, Ian P. Kirk, et al.. (1999). The P-2t antagonist AR-C69931MX is a more effective inhibitor of ADP-induced platelet aggregation than clopidogrel.. Blood. 94. 12 indexed citations
10.
Ingall, Anthony H., John Dixon, Andrew Bailey, et al.. (1999). Antagonists of the Platelet P2T Receptor:  A Novel Approach to Antithrombotic Therapy. Journal of Medicinal Chemistry. 42(2). 213–220. 245 indexed citations
11.
Humphries, Robert G., Wendy Tomlinson, J. A. Clegg, et al.. (1995). Pharmacological profile of the novel P2T‐purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo. British Journal of Pharmacology. 115(6). 1110–1116. 39 indexed citations
12.
Humphries, Robert G., et al.. (1994). FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T‐purinoceptors. British Journal of Pharmacology. 113(3). 1057–1063. 86 indexed citations
13.
Humphries, Robert G., et al.. (1990). Inhibition of Collagen- and ADP-Induced Platelet Aggregation by Substance P In Vivo. Journal of Cardiovascular Pharmacology. 16(2). 292–297. 9 indexed citations
14.
Weightman, D. R., Dennis J. Shale, & Wendy Tomlinson. (1981). A rapid radioassay for human IgG produced in lymphocyte in vitro culture systems. Journal of Immunological Methods. 46(3). 307–312. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026